We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$84.9B
AUM Growth
+$3.96B
Cap. Flow
-$732M
Cap. Flow %
-0.86%
Top 10 Hldgs %
17.12%
Holding
814
New
62
Increased
269
Reduced
330
Closed
71

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$415M
2
PHG icon
Philips
PHG
+$332M
3
TXN icon
Texas Instruments
TXN
+$300M
4
GE icon
GE Aerospace
GE
+$283M
5
DVA icon
DaVita
DVA
+$262M

Sector Composition

Rank Sector Weight
1 Financials 28.58%
2 Technology 16.65%
3 Healthcare 11.71%
4 Industrials 11.38%
5 Energy 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IR icon
276
Ingersoll Rand
IR
$30.4B
$35.6M 0.04%
1,049,064
+91,034
+10% +$2.71M
VNOM icon
277
Viper Energy
VNOM
$15.9B
$34.9M 0.04%
1,496,750
-630,600
-30% -$12.8M
CBM
278
DELISTED
Cambrex Corporation
CBM
$34.1M 0.04%
709,786
+384,897
+118% +$19.1M
NGHC
279
DELISTED
National General Holdings Corp
NGHC
$34M 0.04%
1,732,176
+844,801
+95% +$17.3M
TXN icon
280
Texas Instruments
TXN
$237B
$33.6M 0.04%
321,330
-3,081,015
-91% -$300M
XOG
281
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$33.3M 0.04%
2,327,963
+1,811,782
+351% +$27.7M
KOS icon
282
Kosmos Energy
KOS
$1.63B
$32.7M 0.04%
4,774,426
-1,150,154
-19% -$8.76M
AEGN
283
DELISTED
Aegion Corp
AEGN
$32.5M 0.04%
1,279,802
+66,343
+5% +$1.67M
NSIT icon
284
Insight Enterprises
NSIT
$4.62B
$31.7M 0.04%
827,489
+85,410
+12% +$3.49M
CIEN icon
285
Ciena
CIEN
$54.5B
$31M 0.04%
+1,482,814
New +$31.4M
ACRE
286
Ares Commercial Real Estate
ACRE
$259M
$30.9M 0.04%
2,391,462
+188,716
+9% +$2.51M
SCHW
287
Charles Schwab
SCHW
$191B
$30.7M 0.04%
598,544
-33,603
-5% -$1.58M
SYNH
288
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$30.4M 0.04%
+697,180
New +$32.6M
GVA icon
289
Granite Construction
GVA
$5.49B
$29.6M 0.03%
467,004
+2,391
+0.5% +$149K
ESRX
290
DELISTED
Express Scripts Holding Company
ESRX
$29.5M 0.03%
395,065
-442,389
-53% -$28.3M
INVX
291
Innovex International
INVX
$2.11B
$29.4M 0.03%
617,025
+250,480
+68% +$11.2M
OC icon
292
Owens Corning
OC
$11.2B
$29.3M 0.03%
318,889
-137,314
-30% -$11.6M
FCN icon
293
FTI Consulting
FCN
$4.22B
$29M 0.03%
675,935
+118,774
+21% +$4.85M
OI icon
294
O-I Glass
OI
$1.14B
$28.6M 0.03%
1,288,279
+405,887
+46% +$9.69M
RPXC
295
DELISTED
RPX Corporation
RPXC
$28.5M 0.03%
2,121,334
+180,911
+9% +$2.39M
BND icon
296
Vanguard Total Bond Market
BND
$161B
$27.9M 0.03%
+342,381
New +$28M
AGG icon
297
iShares Core US Aggregate Bond ETF
AGG
$138B
$27.9M 0.03%
+255,268
New +$27.9M
WAFD icon
298
WaFd
WAFD
$2.67B
$27.6M 0.03%
805,973
-57,341
-7% -$1.97M
NCI
299
DELISTED
Navigant Consulting, Inc.
NCI
$27.3M 0.03%
1,408,791
+111,074
+9% +$2.02M
MDRX
300
DELISTED
Veradigm Inc. Common Stock
MDRX
$27.2M 0.03%
1,870,243
-14,348
-0.8% -$199K

Similar funds

Boston Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Partners held 814 positions worth $84.9B, up 4.9% from $80.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Partners's Q4 2017 filing shows 62 new, 269 increased, 330 reduced and 71 closed positions. Its largest new stake was Everest Group: 1,740,653 shares worth $385M. The largest sale was Abbott, an estimated $415M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Healthcare.

  • Boston Partners's largest Q4 2017 buy was Everest Group: 1,740,653 shares worth $385M.
  • Boston Partners added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $398M increase.
  • Boston Partners's biggest Q4 2017 reduction was Abbott, cutting an estimated $415M.
  • Boston Partners fully exited Philips in Q4 2017, selling an estimated $332M.
  • Boston Partners's ten largest holdings make up 17% of its $84.9B portfolio in Q4 2017.
  • Boston Partners opened 62 new positions and closed 71 in Q4 2017.
  • Boston Partners's portfolio value rose 4.9% quarter-over-quarter to $84.9B.

Based on Boston Partners's 13F filing for Q4 2017, filed 1 Feb 2018.